SMTL ID : 8aup.1 (1 other biounit)

Structure of hARG1 with a novel inhibitor.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.17 Å

Oligo State

homo-trimer

Ligands

6 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 6 residues within 4Å: Chain A: D.124, H.126, D.232, D.234 Ligands: MN.2, O93.3 5 PLIP interactions: 5 interactions with chain A Metal complexes: A:D.124, A:H.126, A:D.232, A:D.234, A:D.234 MN.2: 6 residues within 4Å: Chain A: H.101, D.124, D.128, D.232 Ligands: MN.1, O93.3 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.101, A:D.124, A:D.128, A:D.232 MN.5: 6 residues within 4Å: Chain B: D.124, H.126, D.232, D.234 Ligands: MN.6, O93.7 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:D.124, B:H.126, B:D.232, B:D.234, B:D.234 MN.6: 6 residues within 4Å: Chain B: H.101, D.124, D.128, D.232 Ligands: MN.5, O93.7 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:H.101, B:D.124, B:D.128, B:D.232 MN.8: 6 residues within 4Å: Chain C: D.124, H.126, D.232, D.234 Ligands: MN.9, O93.10 5 PLIP interactions: 5 interactions with chain C Metal complexes: C:D.124, C:H.126, C:D.232, C:D.234, C:D.234 MN.9: 6 residues within 4Å: Chain C: H.101, D.124, D.128, D.232 Ligands: MN.8, O93.10 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:H.101, C:D.124, C:D.128, C:D.232

3 x O93: 2-[(1~{R},3~{R},4~{S})-3-azanyl-3-carboxy-4-[(dimethylamino)methyl]cyclohexyl]ethyl-$l^{3}-oxidanyl-bis(oxidanyl)boron(Non-covalent)

O93.3: 17 residues within 4Å: Chain A: H.101, D.124, H.126, D.128, N.130, T.136, S.137, H.141, G.142, D.183, E.186, D.232, D.234, T.246, E.277 Ligands: MN.1, MN.2 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:T.246 Hydrogen bonds: A:N.130, A:S.137, A:H.141, A:D.183, A:D.234 Water bridges: A:D.128, A:D.183, A:T.246, A:E.277 Salt bridges: A:D.181, A:D.183 O93.7: 17 residues within 4Å: Chain B: H.101, D.124, H.126, D.128, N.130, T.136, S.137, H.141, G.142, D.183, E.186, D.232, D.234, T.246, E.277 Ligands: MN.5, MN.6 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:T.246 Hydrogen bonds: B:N.130, B:S.137, B:H.141, B:D.183, B:D.183, B:T.246, B:T.246 Water bridges: B:S.137, B:N.139, B:D.183, B:T.246 Salt bridges: B:D.183 O93.10: 16 residues within 4Å: Chain C: H.101, D.124, H.126, D.128, N.130, T.136, S.137, H.141, D.183, E.186, D.232, D.234, T.246, E.277 Ligands: MN.8, MN.9 13 PLIP interactions: 13 interactions with chain C Hydrophobic interactions: C:T.246 Hydrogen bonds: C:H.126, C:S.137, C:D.183, C:D.234, C:E.277 Water bridges: C:T.135, C:T.135, C:S.137, C:S.137, C:D.183, C:T.246 Salt bridges: C:D.183

1 x HEZ: HEXANE-1,6-DIOL(Non-functional Binders)

HEZ.4: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Borek, B. et al., Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy. Mol.Cancer Ther. (2023)

Release Date

2023-03-29

Peptides

Arginase-1: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

C
E

Arginase-1

Related Entries With Identical Sequence